THE EFFECT OF VANCOMYCIN AND LINEZOLID ON THE TREATMENT AND OUTCOMES OF PRESUMED MRSA PNEUMONIA

被引：0
|
作者：
Kinney, Justin
Pop, Lia
Lowe, Andrew
机构：
来源：
CRITICAL CARE MEDICINE | 2015年 / 43卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
451
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Linezolid versus vancomycin for MRSA nosocomial pneumonia
    不详
    FUTURE MICROBIOLOGY, 2010, 5 (12) : 1763 - 1763
  • [2] TREATMENT OF MRSA PNEUMONIA: ECONOMICAL AND CLINICAL COMPARISON OF LINEZOLID VERSUS VANCOMYCIN
    Wilke, M.
    Petrik, C.
    Weber, B.
    Kloss, S.
    VALUE IN HEALTH, 2014, 17 (07) : A669 - A669
  • [3] The ZEPHyR study: A randomized comparison of linezolid and vancomycin for MRSA pneumonia
    Chavanet, P.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (11-12): : 451 - 455
  • [4] The Effects of Obesity on the Comparative Effectiveness of Linezolid and Vancomycin in MRSA Pneumonia
    Caffrey, Aisling R.
    Noh, Eunsun
    Morrill, Haley J.
    LaPlante, Kerry L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 16 - 17
  • [5] COMPARISON OF TEDIZOLID, LINEZOLID, AND VANCOMYCIN FOR MRSA PNEUMONIA IN A NEUTROPENIC MOUSE MODEL
    Kidd, James
    Abdelraouf, Kamilia
    Nicolau, David
    CRITICAL CARE MEDICINE, 2019, 47
  • [6] LINEZOLID FOR THE TREATMENT OF PATIENTS WITH CONFIRMED MRSA NOSOCOMIAL PNEUMONIA IN NANJING, CHINA: A COST EFFECTIVE ALTERNATIVE TO VANCOMYCIN
    Tan, S. C.
    Li, Q.
    Chen, Y.
    Hajek, P.
    Weinstein, D.
    Patel, D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A353 - A353
  • [7] Vancomycin or linezolid empiric MRSA coverage with potential ventilator-associated pneumonia has no benefit or effect on outcomes: antibiotic stewardship implications
    Cunha, Burke A.
    Jaber, Nora
    Blum, Sharon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (05) : 733 - 734
  • [8] Total treatment cost of linezolid compared to vancomycin in MRSA infections
    Borgman, B.
    Ekman, M.
    VALUE IN HEALTH, 2008, 11 (03) : A102 - A102
  • [9] Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia
    Huon, J. F.
    Boutoille, D.
    Caillon, J.
    Orain, J.
    Crochette, N.
    Potel, G.
    Abgueguen, P.
    Moal, F.
    Navas, D.
    MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (03): : 252 - 256
  • [10] Positive Phase IV results suggest higher rates of success for linezolid versus vancomycin for the treatment of MRSA nosocomial pneumonia
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (12) : 1330 - 1330
12345